首页|米力农联合参麦注射液治疗缺血性心肌病疗效观察

米力农联合参麦注射液治疗缺血性心肌病疗效观察

扫码查看
观察米力农联合参麦注射液对缺血性心肌病患者疗效观察。方法:选取缺血性心肌病患者80例,随机分为治疗组和对照组,每组各40例,治疗组常规给予血管扩张剂、利尿剂、β受体阻滞剂、洋地黄等药物,对照组在常规组治疗基础上加用米力农和参麦注射液,分别治疗7d和14d。结果:治疗2周后,观察组心脏超声LVEF值及6rain步行距离较常规组增加更为显著。观察组治疗率明显优于治疗组,两组比较差异有统计学意义(P﹤0.05)。结论:米力农联合参麦注射液可明显改善缺血性心肌病患者各项心功能指标,疗效显著,且无明显不良反应。
Objective Effects of milrinonecombined with Shenmai injectionto observe thecurative effectof patients with ischemic cardiomyopathy. Method We selected 80 cases of patients with ischemic cardiomyopathy, were randomly divided into treatment group and control group, 40 cases in each group, the treatment group were given conventional vasodilators, diuretics, beta blockers, digitalis drugs, control group based on conventional therapy plus milrinone and Shenmai injection, respectively, for 7 d and 14 d. Result After 2 weeks treatment, the observation group, cardiac ultrasound LVEF value and 6 rain walking distance than the conventional group increased more significantly. In the observation group was obviously better than that of treatment group, there was significant difference between two groups (P﹤0.05). Conclusion Milrinone combined with Shenmai injection can improve the cardiac function indexes in patients with ischemic cardiomyopathy, obvious curative effect, and no obvious adverse reaction.

MyocardialischemiaMilrinoneShenmai InjectionThe heart function index

心肌缺血 米力农 参麦注射液 心功能指标

2014

中外健康文摘
中国中医药报社

中外健康文摘

影响因子:0.016
ISSN:1672-5085
年,卷(期):2014.(23)
  • 3